Epilepsy Medication Market Growth, Key Players and Trends (2024 – 2032)
The global market for epilepsy medications was valued at USD 9.50 billion in 2023 and is expected to grow to USD 15.16 billion by 2032. This growth reflects a compound annual growth rate (CAGR) of 5.1% from 2024 to 2032.
Download statistics of this report @ https://www.towardshealthcare.com/download-statistics/5144
Report Highlights:
- Third-generation anti-epileptic drugs were the top revenue generators in 2022, accounting for 37% of the market share.
- Hospital pharmacies made up the largest share of the market in 2022, holding 46%.
- North America led the epilepsy medication market in 2022, with a 38% market share.
- As of February 2024, the World Health Organization estimates that about 50 million people in the U.S. have epilepsy, and they face an increased risk of premature death.
About Epilepsy:
Epilepsy is a neurological condition characterized by recurring seizures, which occur when there are sudden bursts of electrical activity in the brain that disrupt its normal function. The symptoms of epilepsy can vary widely between individuals, ranging from mild to severe. Seizures may include convulsions, muscle spasms, loss of consciousness, or unusual movements. Some individuals may experience blank staring or other psychic symptoms like fear or déjà vu before a seizure. After a seizure, people might feel confused, forgetful, or have difficulty speaking.
Treating epilepsy is vital for improving the quality of life of those affected by the condition. Effective treatment aims to reduce the frequency and severity of seizures, making everyday tasks safer and preventing accidents, such as those that can occur while driving or swimming.
Epilepsy can be thought of as an “electrical storm” in the brain, where unexpected bursts of electrical signals cause seizures. These seizures can take different forms, such as uncontrollable muscle jerks or moments of blank staring, which can feel like a brief disconnection from the surroundings.
Epilepsy Drugs Market Companies
- Sanofi
- Pfizer, Inc.
- UCB S.A
- Belgium
- Otsuka America Pharmaceutical, Inc.
- Novartis AG
- GlaxoSmithKline plc.
- Abbott Laboratories, Inc.
- Neurelis Inc.
- Jazz Pharmaceuticals plc.
Our Table of Content (TOC) covers key healthcare market segments, materials, technologies and trends—helping you navigate market shifts and make informed decisions: https://www.towardshealthcare.com/table-of-content/epilepsy-drugs-market-sizing
Access exclusive insight now @ https://www.towardshealthcare.com/price/5144
We’ve prepared a service to support you. Please feel free to contact us at sales@towardshealthcare.com
Web: https://www.towardshealthcare.com
Visit Dental Specifics: https://www.towardsdental.com
Get the latest insights on industry segmentation with our Annual Membership: Get a Subscription
For Latest Update Follow Us: https://www.linkedin.com/company/towards-healthcare
